glp-1 tirzepatide dosage Compare Options | Ozempic v Mounjaro | WeightWatchers Study: Tirzepatide produces greater weight
Description
The medication's half-life of approximately five days allows for steady-state concentrations to be reached after about 4 weeks
The metabolic improvements, including better insulin sensitivity and lower androgens, persist for some time after stopping the medication
Food and Drug Administration (FDA) expected to approve Tirzepatide for weight loss later this year
This matters because it shapes how you interpret the risk
